DIAGNOS (CVE:ADK) Hits New 12-Month High – What’s Next?

DIAGNOS Inc. (CVE:ADK) shares reached a new 52-week high during mid-day trading on Monday . The company traded as high as C$0.53 and last traded at C$0.48, with a volume of 253755 shares trading hands. The stock had previously closed at C$0.45.

DIAGNOS Stock Performance

The company has a quick ratio of 0.68, a current ratio of 1.49 and a debt-to-equity ratio of 204.05. The firm has a 50-day moving average of C$0.35 and a 200 day moving average of C$0.28. The stock has a market capitalization of C$59.31 million, a P/E ratio of -12.25 and a beta of 0.50.

Insider Activity at DIAGNOS

In other news, Director Robert Dunn bought 105,000 shares of the stock in a transaction dated Friday, August 28th. The shares were acquired at an average price of C$0.48 per share, with a total value of C$50,400.00. Following the acquisition, the director owned 2,679,920 shares in the company, valued at C$1,286,361.60. This trade represents a 4.08% increase in their ownership of the stock. In the last 90 days, insiders have acquired 433,571 shares of company stock valued at $146,400. 16.81% of the stock is currently owned by insiders.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.